DALLE CARBONARE, L.; BERTOLDO, F.; LO CASCIO, V. Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo, [S. l.], v. 61, n. 1, p. 54–64, 2009. DOI: 10.4081/reumatismo.2009.54. Disponível em: https://www.reumatismo.org/reuma/article/view/reumatismo.2009.54. Acesso em: 26 nov. 2024.